Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - escitalopram oxalate - film-coated tablet - 5 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - escitalopram oxalate - film-coated tablet - 10 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - propofol - emulsion for inj/inf - 10 micromol

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - escitalopram oxalate - film coated tablet - 20 milligram - selective serotonin reuptake inhibitors - antidepressants, selective serotonin reuptake inhibitors - treatment of: major depressive episodes, panic disorder with or without agoraphobia, social anxiety disorder (social phobia), generalised anxiety disorder, obsessive-compulsive disorder

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - escitalopram oxalate - film coated tablet - 10 milligram - selective serotonin reuptake inhibitors - antidepressants, selective serotonin reuptake inhibitors - treatment of: major depressive episodes, panic disorder with or without agoraphobia, social anxiety disorder (social phobia), generalised anxiety disorder, obsessive-compulsive disorder

Ireland - English - HPRA (Health Products Regulatory Authority)

wpr healthcare limited - escitalopram oxalate - film coated tablet - 5 milligram - selective serotonin reuptake inhibitors - antidepressants, selective serotonin reuptake inhibitors - treatment of: major depressive episodes, panic disorder with or without agoraphobia, social anxiety disorder (social phobia), generalised anxiety disorder, obsessive-compulsive disorder

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - diagnostic: intravenous injection of sodium fluorescein dye followed by multiframe photography (angiography) or opthalmoscopic evaluation (angioscopy). used in evaluation of wide range of retinal and choroidal diseases. less commonly used to evaluate abnormalities of the optic nerve and iris. may be used in the diagnosis and management of macular and vascular (including diabetic) diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - fluorescein sodium, quantity: 250 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 01 january 1991 : diagnostic - intravenous injection of sodium fluorescein dye followed by multiframe photography (angiography) or ophthalmoscopic evaluation (angioscopy). used in evaluation of wide range of retinal and choroidal diseases. less commonly used to evaluate abnormalities of the optic nerve and iris. may be used in diagnosis and management of macular and vascular (including diabetes) diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 01 january 1991 : diagnostic - intravenous injection of sodium fluorescein dye followed by multiframe photography (angiography) or ophthalmoscopic evaluation (angioscopy). used in evaluation of wide range of retinal and choroidal diseases. less commonly used to evaluate abnormalities of the optic nerve and iris. may be used in diagnosis and management of macular and vascular (including diabetes) diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - atropine sulfate monohydrate, quantity: 9.9737 mg/ml - eye drops, solution - excipient ingredients: boric acid; disodium edetate; benzalkonium chloride; hypromellose; water for injections - indications as at 06 august 1999: atropt eye drops are indicated where it is necessary to dilate the pupil and paralyse accomodation.